Clinical Trials Directory

Trials / Unknown

UnknownNCT03897153

Evaluation of the SONAS® Ultrasound Device for the Assessment of Bilateral Cerebral Perfusion in Subjects With Acute Stroke

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Burl Concepts, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this clinical investigation is to determine the safety and feasibility of detecting acoustic signals related to blood supply in subjects with acute large vessel occlusion (LVO) stroke by using the SONAS® device.

Detailed description

This clinical investigation will assess the performance of the SONAS® device in subjects with acute stroke admitted to the emergency department or stroke unit within 24 hours of symptoms onset and confirmed occlusion of either the proximal middle, distal M1-segment cerebral arteries, or distal internal carotid arteries (including carotid-T occlusion) by cerebral magnetic resonance imaging (cMRI) or cerebral imaging computed tomography (cCT), including perfusion weighted (pw) imaging sequences, will be considered for the investigation.

Conditions

Interventions

TypeNameDescription
DEVICESONAS® Ultrasound DeviceThe SONAS® Ultrasound Device is intended for non-invasive transcranial ultrasound and used with a commercially approved contrast agent (e.g., Lumason®/SonoVue®).

Timeline

Start date
2019-02-12
Primary completion
2019-10-01
Completion
2019-10-01
First posted
2019-04-01
Last updated
2019-04-01

Locations

2 sites across 2 countries: Austria, Germany

Source: ClinicalTrials.gov record NCT03897153. Inclusion in this directory is not an endorsement.